Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -4.10%1.81B | -6.48%1.21B | -6.05%582.08M | 23.29%2.51B | 24.60%1.88B | 1.3B | 36.95%619.58M | 58.27%2.03B | 1.51B | 89.79%452.4M |
| Operating revenue | -4.10%1.81B | -6.48%1.21B | -6.05%582.08M | 23.29%2.51B | 24.60%1.88B | --1.3B | 36.95%619.58M | 58.27%2.03B | --1.51B | 89.79%452.4M |
| Other operating revenue | ---- | -10.22%14.16M | ---- | 26.84%37.52M | ---- | --15.77M | ---- | 125.83%29.58M | ---- | ---- |
| Total operating cost | -1.58%1.75B | -4.39%1.16B | -5.11%556.73M | 25.95%2.37B | 28.38%1.77B | 1.22B | 586.72M | 57.40%1.88B | 1.38B | |
| Operating cost | -0.93%1.6B | -3.88%1.06B | -4.69%511.94M | 27.69%2.16B | 30.49%1.61B | --1.11B | --537.15M | 58.50%1.69B | --1.24B | ---- |
| Operating tax surcharges | 7.91%5.51M | 6.11%3.61M | 4.13%1.84M | 9.30%7.08M | 4.17%5.11M | --3.4M | --1.77M | 4.26%6.48M | --4.9M | ---- |
| Operating expense | 13.83%21.42M | 20.55%14.45M | 54.20%8.02M | 27.26%25.07M | 34.36%18.82M | --11.98M | --5.2M | 59.58%19.7M | --14.01M | ---- |
| Administration expense | -3.04%32.95M | 4.24%23.3M | 24.60%12.35M | 25.27%50.82M | 15.74%33.98M | --22.35M | --9.91M | 15.81%40.57M | --29.36M | ---- |
| Financial expense | -42.90%12.47M | -48.01%7.89M | -40.15%4.31M | -22.22%26.37M | -15.66%21.85M | --15.17M | --7.2M | 36.97%33.9M | --25.9M | ---- |
| -Interest expense (Financial expense) | -28.17%16.74M | -27.78%11.71M | -27.31%5.67M | -17.68%28.68M | -11.59%23.31M | --16.21M | --7.8M | 40.25%34.84M | --26.36M | ---- |
| -Interest Income (Financial expense) | -156.23%-4.53M | -229.47%-3.99M | -116.75%-1.46M | -116.82%-2.67M | -155.89%-1.77M | ---1.21M | ---673.22K | -799.75%-1.23M | ---691.51K | ---- |
| Research and development | -6.95%73.38M | -12.05%49.56M | -28.28%18.28M | 12.90%104.32M | 13.06%78.87M | --56.35M | --25.49M | 78.40%92.4M | --69.75M | ---- |
| Credit Impairment Loss | -90.88%-13.4M | -402.34%-7.69M | -33.02%-6.79M | 48.49%-7.65M | 55.64%-7.02M | ---1.53M | ---5.11M | -70.27%-14.86M | ---15.83M | ---- |
| Asset Impairment Loss | 47.65%-2.92M | 65.19%-2.43M | 71.23%-1.02M | 44.37%-5.46M | 6.61%-5.57M | ---6.97M | ---3.55M | -83.05%-9.81M | ---5.97M | ---- |
| Other net revenue | -28.77%18.82M | -27.78%14.07M | -67.07%2.3M | 175.63%40.39M | 5,253.24%26.42M | 19.48M | 6.98M | -48.45%14.65M | -512.78K | 0 |
| Fair value change income | ---- | ---- | ---- | --0 | ---- | --36.62K | --170.03K | --0 | --597.55K | ---- |
| Invest income | -71.33%1.1M | -78.40%645.2K | -61.41%638.63K | 623.12%4.32M | --3.85M | --2.99M | --1.66M | --597.55K | ---- | ---- |
| Asset deal income | ---4.05K | ---4.05K | ---- | --0 | ---- | ---- | ---- | -98.20%92.72K | --92.72K | ---- |
| Other revenue | -3.20%34.04M | -5.69%23.54M | -31.41%9.47M | 27.30%49.18M | 70.75%35.17M | --24.96M | --13.81M | 3.39%38.63M | --20.6M | ---- |
| Operating profit | -41.85%79.1M | -36.35%63.14M | -30.62%27.64M | 6.46%175.74M | 5.20%136.03M | 99.19M | 39.84M | 41.27%165.08M | 129.3M | |
| Add:Non operating Income | 238.63%258.28K | 71.52%121.06K | 365.63%14.9K | -33.76%77.07K | -7.27%76.27K | --70.58K | --3.2K | -68.74%116.35K | --82.25K | ---- |
| Less:Non operating expense | -36.12%267K | -83.46%29.73K | 1,898.37%3.48M | -5.19%474.92K | -16.43%417.99K | --179.75K | --173.96K | 15.48%500.93K | --500.19K | ---- |
| Total profit | -41.71%79.09M | -36.18%63.23M | -39.04%24.18M | 6.47%175.35M | 5.28%135.69M | 99.08M | 39.67M | 41.01%164.7M | 128.88M | |
| Less:Income tax cost | -77.13%2.51M | -54.52%3.43M | -43.52%1.47M | -0.87%13.77M | 5.55%10.97M | --7.54M | --2.6M | 42.74%13.89M | --10.39M | ---- |
| Net profit | -38.60%76.58M | -34.67%59.8M | -38.73%22.72M | 7.14%161.58M | 5.26%124.72M | 91.54M | 37.08M | 40.85%150.81M | 118.49M | |
| Net profit from continuing operation | -38.60%76.58M | -34.67%59.8M | -38.73%22.72M | 7.14%161.58M | 5.26%124.72M | --91.54M | --37.08M | 40.85%150.81M | --118.49M | ---- |
| Net profit of parent company owners | -38.60%76.58M | -34.67%59.8M | -38.73%22.72M | 7.14%161.58M | 5.26%124.72M | --91.54M | 27.56%37.08M | 40.85%150.81M | --118.49M | 174.82%29.06M |
| Earning per share | ||||||||||
| Basic earning per share | -53.96%0.2059 | -51.01%0.1608 | -54.03%0.0611 | 1.50%0.5488 | 5.27%0.4472 | --0.3282 | --0.1329 | 40.84%0.5407 | --0.4248 | ---- |
| Diluted earning per share | -53.96%0.2059 | -51.01%0.1608 | -54.03%0.0611 | 1.50%0.5488 | 5.27%0.4472 | --0.3282 | --0.1329 | 40.84%0.5407 | --0.4248 | ---- |
| Other composite income | 0 | 0 | ||||||||
| Total composite income | -38.60%76.58M | -34.67%59.8M | -38.73%22.72M | 7.14%161.58M | 5.26%124.72M | 91.54M | 37.08M | 40.85%150.81M | 118.49M | |
| Total composite income of parent company owners | -38.60%76.58M | -34.67%59.8M | -38.73%22.72M | 7.14%161.58M | 5.26%124.72M | --91.54M | --37.08M | --150.81M | --118.49M | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.